81.32
Tarsus Pharmaceuticals Inc Aktie (TARS) Neueste Nachrichten
Tarsus Pharmaceuticals chief medical officer talks AI in eye care - Healthcare Brew
Barclays Initiates Coverage on Tarsus Pharmaceuticals (TARS) with Overweight Rating | TARS Stock News - GuruFocus
Jump Financial LLC Purchases 188,317 Shares of Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Norges Bank Acquires Shares of 471,354 Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Tarsus Pharmaceuticals (NASDAQ:TARS) Sets New 12-Month HighHere's What Happened - MarketBeat
Tarsus Pharmaceuticals stock hits all-time high at 83.67 USD - Investing.com
Tarsus Pharmaceuticals Leads Six-Month Stock Performance with 85.5% Return - Markets Mojo
Quantbot Technologies LP Purchases 24,319 Shares of Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Can Tarsus Pharmaceuticals Stock Still Offer Value After Its 48% 2025 Rally? - Yahoo Finance
Quadrature Capital Ltd Invests $588,000 in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
(TARS) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
Virtus Investment Advisers LLC Buys 3,827 Shares of Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Tarsus Pharmaceuticals, Inc. $TARS Shares Bought by Prudential Financial Inc. - MarketBeat
Geode Capital Management LLC Raises Position in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Can Tarsus Pharmaceuticals Inc. stock double in next 5 years - moha.gov.vn
Why Tarsus Pharmaceuticals Inc. stock could rally in 2025Portfolio Gains Summary & Risk Adjusted Buy/Sell Alerts - moha.gov.vn
Magnetar Financial LLC Takes $596,000 Position in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Tarsus Pharmaceuticals (NASDAQ:TARS) Hits New 1-Year HighHere's What Happened - MarketBeat
Tarsus to Participate in Upcoming Investor Conference - The Manila Times
Tarsus Pharmaceuticals, Inc.'s (NASDAQ:TARS) Profit Outlook - 富途牛牛
Tarsus Pharmaceuticals, Inc. $TARS Shares Acquired by SG Americas Securities LLC - MarketBeat
Will Tarsus Pharmaceuticals Inc. stock maintain dividend yieldMarket Trend Summary & Fast Gain Swing Alerts - newser.com
Tarsus Pharmaceuticals (TARS) Is Up 6.1% After Analyst Upgrades Highlight XDEMVY Sales Momentum - Sahm
Mizuho Begins Coverage on Tarsus Pharmaceuticals (NASDAQ:TARS) - MarketBeat
Tarsus Pharmaceuticals: Xdemvy Momentum Continues In Q3 (NASDAQ:TARS) - Seeking Alpha
Mizuho Initiates Coverage on Tarsus Pharmaceuticals (TARS) with Outperform Rating | TARS Stock News - GuruFocus
Mizuho initiates coverage on Tarsus Pharmaceuticals stock with Outperform rating - Investing.com Canada
Mizuho Initiates Tarsus Pharmaceuticals at Outperform With $100 Price Target - MarketScreener
Will Tarsus Pharmaceuticals Inc. stock remain a Wall Street favoriteWeekly Stock Recap & Daily Oversold Bounce Ideas - newser.com
Price-Driven Insight from (TARS) for Rule-Based Strategy - news.stocktradersdaily.com
Will Tarsus Pharmaceuticals Inc. stock outperform Nasdaq indexJuly 2025 Spike Watch & Growth Focused Stock Reports - newser.com
What catalysts could drive Tarsus Pharmaceuticals Inc. stock higherMarket Movement Recap & Daily Oversold Stock Bounce Ideas - newser.com
Is Tarsus Pharmaceuticals Inc. stock poised for growth2025 Stock Rankings & Daily Entry Point Trade Alerts - newser.com
Can Tarsus Pharmaceuticals Inc. stock resist market sell offs2025 Retail Activity & Real-Time Price Movement Reports - newser.com
Tarsus Pharmaceuticals (NASDAQ:TARS) Sets New 1-Year HighTime to Buy? - MarketBeat
Long term hold vs stop loss in Tarsus Pharmaceuticals Inc.Market Performance Summary & Fast Entry Momentum Alerts - newser.com
Midday Stock Roundup: Eledon Falls after Trial Report - Orange County Business Journal
Tarsus Pharmaceuticals stock hits all-time high at 76.85 USD By Investing.com - Investing.com Canada
Tarsus Pharmaceuticals stock hits all-time high at 76.85 USD - Investing.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):